Answers are grounded in this paper and cite their sources.
Alopecia areata (AA) is a chronic inflammatory disease distinguished by non-scarring alopecia. The latest evidence suggests it is a T cell-mediated autoimmune disease that manifests in genetically susceptible individuals. In contrast to adult-onset AA, clinical traits and treatment of pediatric AA have been investigated very little. We hereby report a pediatric case of recalcitrant AA treated with a 308 nm excimer lamp and topical tofacitinib 2% gel.
No takes yet. Share an insight, caveat, or question.
Dineshkumar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: